Barclays has issued a research note forecasting slower growth for Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) due to continued destocking of cold and flu products and a sluggish recovery in infant formula. The investment banking arm of the high street lender now expects organic sales growth of 0.4% for the second quarter, down from the previous estimate of 1.6%.
Reckitt, a consumer goods producer, has experienced a decline in share price due to concerns over its nutrition business and ongoing legal issues. Despite underwhelming business performance, Reckitt's hygiene brands have shown growth and the company forecasts 2-4% net revenue growth for the current year. The company's share price has been overly punished, presenting an attractive valuation opportunity with a P/E ratio of 14 and strong brand assets.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the consumer goods giant, could have an activist investor to worry about, adding yet another worry for management as its shares continue to slip. Eminence, the asset management firm known for spearheading an activist campaign against Ladbrokes owner Entain, has built around a 0.5% stake in Reckitt, reports revealed.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the consumer goods giant, could have an activist investor to worry about, adding yet another worry for management as its shares continue to slip. Eminence, the asset management firm known for spearheading an activist campaign against Ladbrokes owner Entain, has built around a 0.5% stake in Reckitt, reports revealed.